Menu

02/05/11: Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series

This is an extract from a recent press release from Ahram Biosystems

“Palm PCR F1-12, the economy model of the innovative Palm PCR series, is now on the market. It can amplify up to 1 kbp within 30 minutes in a small handheld, portable format

SANTA CLARA, Calif., April 23, 2012 /PRNewswire/ — Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of Palm PCR F1-12, the economy model of its innovative portable PCR system. The F1-12 system is a cost-effective, high-performance portable PCR system, delivering PCR amplification with high speed and sensitivity in a fully portable format.

The Palm PCR F1-12 system provides three “Standard Fast” speed levels delivering 30-cycle PCR amplification within 30 minutes down to 24 minutes. The amplification sensitivity reaches to near single-copy level below 10 copies. The dynamic range of the PCR amplification is up to 1 kbp.

Like other Palm PCR series, it is battery-powered (more than 4 hours of continuous operation on a single charge) and represents high temperature uniformity (less than +/- 0.1 degrees C) and a small footprint and light weight (71 mm x 121 mm x 47 mm or 2.8″ x 4.76″ x 1.85″, 350 g).

The high speed and high sensitivity of the F1-12 system and its affordable price make it ideal for a wide range of downstream applications that require fast and sensitive nucleic acid amplification. Examples include POCT (point-of-care testing), food quality assurance, forensics, educational uses and many other applications of genetic identification purposes. The battery-powered, full portability makes the F1-12 system particularly invaluable where in-field or on-site PCR amplification is crucial. The Palm PCR F1-12 system enables users to perform highly sensitive and accurate PCR amplification in a fully portable format while saving both money and time.”

You can read the full thing: Press Release-Ahram Biosystems-23 APRIL 2012.

 

Comments are closed.